Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute USD Opportunity Assessment & Y-o-Y Analysis, 2022-2035
2.3 Market Size & Forecast, By Segmentation, 2022-2035
2.3.1 Market Size By Treatment
2.3.2 Market Size By Procedure
2.3.3 Market Size By Product
2.3.4 Market Size By End-Use
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Treatment Type & Therapeutic Modality Metrics
4.1.1 Pharmacological therapies – alpha-blockers, 5-alpha reductase inhibitors, combination therapy
4.1.2 Minimally invasive surgical therapies (MIST)
4.1.3 Surgical interventions – TURP (Transurethral Resection of Prostate), open prostatectomy
4.1.4 Laser therapies (HoLEP, GreenLight laser therapy)
4.1.5 UroLift and prostatic urethral lift systems
4.1.6 Water vapor thermal therapy (Rezum)
4.1.7 Watchful waiting and lifestyle management approaches
4.2 Drug Therapy Performance Metrics
4.2.1 Symptom score reduction (IPSS improvement rates)
4.2.2 Urinary flow rate improvement (Qmax increase)
4.2.3 Time to symptom relief onset
4.2.4 Prostate size reduction efficiency (5-ARI effectiveness)
4.2.5 Drug adherence and persistence rates
4.2.6 Side effect incidence (sexual dysfunction, hypotension)
4.2.7 Long-term efficacy and recurrence control
4.3 Surgical & Procedural Metrics
4.3.1 Procedure success rate across TURP and laser therapies
4.3.2 Operative time and hospital stay duration
4.3.3 Blood loss and transfusion requirement rates
4.3.4 Catheterization duration post-procedure
4.3.5 Re-intervention and retreatment rates
4.3.6 Complication rates (incontinence, strictures, infection)
4.3.7 Surgeon learning curve and procedural efficiency
5. BPH Treatment Market Segmental Analysis & Forecast, By Treatment, 2022 – 2035, Value (USD Billion)
5.1 Introduction
5.2 Minimal Invasive Surgery
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Invasive Surgery
6. BPH Treatment Market Segmental Analysis & Forecast, By Procedure, 2022 – 2035, Value (USD Billion)
6.1 Introduction
6.2 Transurethral Resection of the Prostate
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Prostate Laser Surgery
6.4 Transurethral Microwave Thermotherapy
6.5 Transurethral Needle Ablation of the Prostate
6.6 Prostatic Urethral Lift
6.7 Water Vapor Therapy
6.8 Robot-Assisted Laparoscopic Prostatectomy
6.9 Aquablation Therapy
6.10 Prostatic Artery Embolization
6.11 Open Prostatectomy
6.12 Bipolar Enucleation of Prostate
6.13 Transurethral Incision of the Prostate
6.14 High-Intensity Focused Ultrasound
7. BPH Treatment Market Segmental Analysis & Forecast, By Product, 2022 – 2035, Value (USD Billion)
7.1 Introduction
7.2 Resectoscopes
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Urology Laser
7.4 Radiofrequency Ablation
7.5 Electrodes
7.6 Catheters
7.7 Prostatic Stents
7.8 Implants
7.9 Others
8. BPH Treatment Market Segmental Analysis & Forecast, By End-Use, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2035
8.3 Specialty Facilities
8.4 Research and Manufacturing
9. BPH Treatment Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 BPH Treatment Market Size & Forecast, By Treatment, 2022 – 2035
9.2.3 BPH Treatment Market Size & Forecast, By Procedure, 2022 – 2035
9.2.4 BPH Treatment Market Size & Forecast, By Product, 2022 – 2035
9.2.5 BPH Treatment Market Size & Forecast, By End-Use, 2022 – 2035
9.2.6 BPH Treatment Market Size & Forecast, By Country, 2022 – 2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 BPH Treatment Market Size & Forecast, By Treatment, 2022 – 2035
9.3.3 BPH Treatment Market Size & Forecast, By Procedure, 2022 – 2035
9.3.4 BPH Treatment Market Size & Forecast, By Product, 2022 – 2035
9.3.5 BPH Treatment Market Size & Forecast, By End-Use, 2022 – 2035
9.3.6 BPH Treatment Market Size & Forecast, By Country, 2022 – 2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 BPH Treatment Market Size & Forecast, By Treatment, 2022 – 2035
9.4.3 BPH Treatment Market Size & Forecast, By Procedure, 2022 – 2035
9.4.4 BPH Treatment Market Size & Forecast, By Product, 2022 – 2035
9.4.5 BPH Treatment Market Size & Forecast, By End-Use, 2022 – 2035
9.4.6 BPH Treatment Market Size & Forecast, By Country, 2022 – 2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 BPH Treatment Market Size & Forecast, By Treatment, 2022 – 2035
9.5.3 BPH Treatment Market Size & Forecast, By Procedure, 2022 – 2035
9.5.4 BPH Treatment Market Size & Forecast, By Product, 2022 – 2035
9.5.5 BPH Treatment Market Size & Forecast, By End-Use, 2022 – 2035
9.5.6 BPH Treatment Market Size & Forecast, By Country, 2022 – 2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 BPH Treatment Market Size & Forecast, By Treatment, 2022 – 2035
9.6.3 BPH Treatment Market Size & Forecast, By Procedure, 2022 – 2035
9.6.4 BPH Treatment Market Size & Forecast, By Product, 2022 – 2035
9.6.5 BPH Treatment Market Size & Forecast, By End-Use, 2022 – 2035
9.6.6 BPH Treatment Market Size & Forecast, By Country, 2022 – 2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Medtronic plc
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Boston Scientific Corporation
10.6.3 Teleflex Incorporated
10.6.4 PROCEPT BioRobotics Corporation
10.6.5 Lumenis Ltd.
10.6.6 Karl Storz SE & Co. KG
10.6.7 Olympus Corporation
10.6.8 Richard Wolf GmbH
10.6.9 NovaTract Surgical Inc.
10.6.10 Angiodynamics Inc.
10.6.11 Laborie Medical Technologies
10.6.12 Dornier MedTech GmbH
10.6.13 Urologix LLC
10.6.14 Nuo Therapy Inc.
10.6.15 IPG Photonics Corporation
10.6.16 nLIGHT Inc.
10.6.17 American Medical Systems (Boston Scientific)
10.6.18 Coloplast A/S
10.6.19 Urotronic Inc.
10.6.20 Insightec Ltd.
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures